Your session is about to expire
← Back to Search
ACUVUE OASYS MAX 1-Day Multifocal, Dailies Total1 Multifocal for Presbyopia (GIRAFFE Trial)
N/A
Waitlist Available
Led By Lyndon Jones, PhD, FCOptom
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
GIRAFFE Trial Summary
This trial aims to compare the vision quality of people wearing two different types of contact lenses for presbyopia.
Who is the study for?
This trial is for people with presbyopia, which is a common condition where the eyes lose the ability to see close objects clearly. Participants should be current wearers of multifocal lenses and willing to try two different brands.Check my eligibility
What is being tested?
The study measures how well participants can read small print (logMAR visual acuity) when wearing Dailies Total1 Multifocal lenses compared to ACUVUE OASYS MAX 1-DAY Multifocal lenses.See study design
What are the potential side effects?
Potential side effects from wearing these contact lenses may include eye discomfort, dryness, redness, blurred vision, and a feeling of something in the eye.
GIRAFFE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
High contrast visual acuity (logMAR) at 40cm
High contrast visual acuity (logMAR) at 6m
GIRAFFE Trial Design
2Treatment groups
Experimental Treatment
Group I: Dailies Total1 Multifocal, ACUVUE OASYS MAX 1-Day MultifocalExperimental Treatment2 Interventions
Fit participant with Dailies Total1 Multifocal first, and with ACUVUE OASYS MAX 1-Day Multifocal second.
Group II: ACUVUE OASYS MAX 1-Day Multifocal, Dailies Total1 MultifocalExperimental Treatment2 Interventions
Fit participant with ACUVUE OASYS MAX 1-Day Multifocal first, and with Dailies Total1 Multifocal second.
Find a Location
Who is running the clinical trial?
University of WaterlooLead Sponsor
124 Previous Clinical Trials
209,318 Total Patients Enrolled
2 Trials studying Presbyopia
51 Patients Enrolled for Presbyopia
Alcon ResearchIndustry Sponsor
704 Previous Clinical Trials
124,471 Total Patients Enrolled
30 Trials studying Presbyopia
5,688 Patients Enrolled for Presbyopia
Lyndon Jones, PhD, FCOptomPrincipal InvestigatorCentre for Ocular Research & Education (CORE)
12 Previous Clinical Trials
421 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any ongoing opportunities for patient enrollment in this clinical trial at the moment?
"As per the information on clinicaltrials.gov, this particular research project is presently not open for recruitment. The trial's initial posting was dated 5th January 2024 and its most recent update occurred on 12th April 2024. Despite this study being inactive in terms of participant enrollment, it is noteworthy that there are currently 27 alternative clinical trials actively seeking candidates to join their respective studies."
Answered by AI
Share this study with friends
Copy Link
Messenger